Apollo Commercial Real Estate Finance Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw a major loan portfolio sale, boosting cash and book value, with management focused on strategic alternatives and capital preservation. Dividend policy targets an 8% yield, and share repurchases have accreted book value. Updates on future strategy are expected soon.
-
A definitive agreement was reached to sell the loan portfolio for 99.7% of commitments, unlocking $1.4 billion in cash and validating book value. The transaction provides a 23% premium to recent trading levels, supports continued dividends, and initiates a strategic review for new opportunities.
Fiscal Year 2025
-
Announced sale of the loan portfolio to Athene, with focus on maximizing value from four retained REO assets. Q4 distributable earnings were $37M, and the loan portfolio grew to $8.8B. Dividend for Q1 2025 is expected at $0.25 per share, with future strategy and distributions under review.
-
Strong Q3 results with $48M net income and $1B in new loan originations. Portfolio growth expected as capital is recycled from focus assets, with robust liquidity and improved market conditions supporting continued earnings momentum.
-
Q2 2025 saw strong loan originations, portfolio growth to $8.6B, and robust earnings, with capital rotation from focused assets expected to drive further gains. Refinancing extended debt maturities, and liquidity was enhanced by new credit facilities.
-
Q1 saw robust loan origination and portfolio growth, with distributable earnings expected to rise above the Q1 trough for the rest of 2025. Active asset management and expanded credit facilities support ongoing capital deployment, while recession risk and construction costs remain key concerns.
Fiscal Year 2024
-
Robust loan originations and repayments in 2024 led to a $7.1B portfolio, with strong dividend coverage and a focus on redeploying capital from non-performing assets. Portfolio growth is expected in 2025, supported by a $1B+ origination pipeline and improving market liquidity.
-
Improved market conditions and robust loan repayments enabled significant new loan commitments and proactive asset management. A major realized loss on a Massachusetts hospital loan impacted GAAP results, but strong liquidity and ongoing portfolio repositioning support future earnings growth.
-
Q2 2024 saw stable earnings, robust loan repayments, and active capital redeployment, with a strong pipeline for new investments. A $90 million CECL allowance is anticipated for a hospital loan due to Steward's bankruptcy, while portfolio and dividend outlooks remain steady.